Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Pharmaceutical Group Sanjing Pharmaceutical is a prominent Chinese pharmaceutical company and a key subsidiary of the Harbin Pharmaceutical Group. The company specializes in the development, manufacturing, and marketing of over-the-counter (OTC) medicines, prescription drugs, and healthcare products. It is particularly renowned for its oral liquid formulations, holding a leading market position in China for its Calcium Gluconate and Zinc Gluconate oral solutions. Sanjing's product portfolio also includes Traditional Chinese Medicines (TCM), such as the widely used Shuanghuanglian Oral Liquid, as well as anti-infectives and cardiovascular treatments. Operating from large-scale, GMP-certified facilities in Harbin, the company leverages advanced production technology to maintain high quality standards. Sanjing remains one of the most recognized pharmaceutical brands in China, supported by an extensive national distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Pharm. Group Sanjing Pharmaceutical.